All posts by medical

Hitachi Partners with ZS Genetics to Commercialize Sequencing Platform – Genetic Engineering & Biotechnology News

Hitachi High Technologies America (HTA) will partner with ZS Genetics to commercialize ZS single-molecule DNA sequencing platform, the companies said today, through a collaboration whose value was not disclosed.

The companies said ZS Genetics proprietary third-generation technologies, based on high-resolution electron microscopy (EM), will allow users for the first time to sequence long reads50,000 or more base-pairsof single DNA molecules at high quality. The company expects to average hundreds of millions of base-pairs of sequencing data per hour.

ZS Genetics says its technology is designed to sequence entire human genomes in days by reading sequences of single DNA molecules that are hundreds of times longer than those read by any other existing technologies, without the need for amplification.

ZS Genetics third-generation sequencing processes DNA samples into single-stranded DNA that is then modified into double-stranded DNA with a few heavy atoms or modified deoxyribonucleotide triphosphates (dNTPs) per base pair. Each dNTP contains a unique label separately identifiable in the electron microscope image, which is captured and analyzed with software that recognizes the DNA and labels.

The technology typically sequences each sample 5 to 10 times, rather than 30 to 50 timesa reduction in oversampling that ZS Genetics says on its website will collapse the informatics costs of sequencing and improve the quality of genomes produced.

Privately held ZS Genetics plans to establish an early-access center in its Wakefield, MA, facility later this year for product and application development, in collaboration with select customer and supply-chain partners it did not name.

The companies did not disclose other details and terms of their strategic product development relationship.

The technical capabilities of our two companies are expected to produce a DNA sequencing platform capable of enabling unique scientific discovery, as well as offering a powerful tool to complement and broaden current short-read sequencing technologies, ZS Genetics CEO John A. McCarthy, Jr., said in a statement. The rapidly increasing complexity of scientific discovery continues to reinforce the need for higher quality and more scientifically rich DNA sequencing capabilities."

Added Phil Bryson, vp and gm of HTAs Nanotechnology Systems Division: We are confident that HTAs decades-long leadership in high-resolution EM for highly complex applications in R&D and industry can translate readily into this powerful and important new application for the life sciences industry.

HTA, a subsidiary of Hitachi High-Technologies Corp., sells and services semiconductor manufacturing equipment, analytical instrumentation, scientific instruments, and bio-related products, as well as industrial equipment, electronic devices, and electronic and industrial materials. HTA is a privately owned global affiliate company operating within the Hitachi Group Companies.

Excerpt from:
Hitachi Partners with ZS Genetics to Commercialize Sequencing Platform - Genetic Engineering & Biotechnology News

Nature Genetics Paper Demonstrates How Inclusion of Bionano Genomics’ Next-Generation Mapping is Essential to … – Yahoo Finance

SAN DIEGO, March 09, 2017 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc., a company focused on genome structure analysis, today highlighted results from a study demonstrating how combining genomic sequencing and mapping technologies, including Bionanos next-generation mapping (NGM), produced the most continuous de novo mammalian assembly to date, of the domestic goat (Capra hircus). The paper, Single-molecule sequencing and chromatin conformation capture enable de novo reference assembly of the domestic goat genome, was published online in advance of print in the March 6, 2017 issue of Nature Genetics (DOI:10.1038/ng.3802).

The paper described the use of single-molecule real-time long-read sequencing for contig formation (PacBios RSII), followed by scaffolding using chromatin interaction mapping (Phase Genomics Hi-C) and optical mapping data (Bionano Genomics Irys). The resulting assembly was polished with paired-end short-read sequencing for sequence accuracy (Illuminas HiSeq).

Hi-C has been gaining popularity for scaffolding de novo assembled genomes. By cross-linking remote regions of chromosomes, Hi-C has the potential to make scaffolds reaching chromosome arm lengths possible. However, this cross-linking does not always enable order and orientation of the contigs to be determined correctly. In the scaffolding of the goat genome described here, Hi-C introduced 7 times more errors than Bionano (21 vs. 3).

Since Bionano NGM is the only non-sequence based scaffolding method, it is the only technology capable of correcting errors inherent to both short-read and long-read sequencing. Bionano genome maps are created completely de novo, and therefore provide an entirely independent assembly with which to compare the sequence contigs. The Nature Genetics paper describes how Bionanos genome maps were able to correct 36 mis-assemblies in the PacBio contigs. Furthermore, Bionano allowed for precise sizing of 79% of the remaining gaps, which is not possible with Hi-C.

Erik Holmlin, Ph.D., CEO of Bionano, commented, This paper follows the recent release of multiple reference-quality human genomes, including the Chinese and Korean reference genomes, all of which included Bionano data to create the most contiguous and accurate assemblies possible. Since the time this study was conducted over 18 months ago, Bionano has significantly advanced its scaffolding tools and with the recently released Saphyr instrument, the cost to map a mammalian genome has decreased six-fold. This publication serves as important validation of NGM as a complementary genomic tool to combine with next-generation sequencing to reveal highly informative native structure of chromosomes.

Bionanos hybrid scaffold pipeline within the Bionano Access analysis and visualization software allows users to combine two genome maps, each created by labeling a different sequence motif with an NGS assembly. This combination typically doubles the contiguity achieved using one genome map, incorporates about 50% more contigs into the assembly, and provides an additional de novo assembly to be used in error correction. Using Saphyr, two mammalian genome maps can be created in a single run, for a total reagent and consumables cost of less than $2000 a fraction of the sequencing and scaffolding cost for the entire project described in this paper, which approached $100,000.

The generated assembly, ARS1, represents an approximate 400-fold improvement in genome continuity due to properly assembled gaps compared to the previously published goat assembly, and better resolves the full structure of large repeats longer than 1 kilobase (kb). ARS1 comprises just 31 scaffolds and 649 gaps covering 30 of the 31 haploid, acrocentric goat chromosomes (excluding only the Y chromosome), which compares favorably to the current human reference (GRCh38), which has 24 scaffolds, 169 unplaced or un-localized scaffolds, and 832 gaps in the primary assembly.

The researchers concluded that the assembly strategy using multiple complementary technologies achieved superior continuity and accuracy, is cost-effective compared to past finishing approaches, and sets a new standard for mammalian genome assembly quality.

The Bionano Access software, which includes two-enzyme hybrid scaffolding and related scaffold editing, will be released as a free download later this month.

Read More

About Bionano Genomics

Bionano Genomics, Inc. provides the Irys and Saphyr systems for next-generation mapping (NGM), which is the leading solution in physical genome mapping. NGM offers customers whole genome analysis tools that reveal true genome structure and enabling researchers to capture whats missing in their data to advance human, plant and animal genomic research. NGM uses NanoChannel arrays to image DNA at the single-molecule level with average single-molecule lengths of about 350,000 base pairs, which leads the genomics industry. The long-range genomic information obtained with NGM detects and deciphers structural variations (SVs), which are large, complex DNA segments involving repeats that are often missed by sequencing technologies and which are a leading cause of inaccurate and incomplete genome assembly.

As a stand-alone tool, NGM enables the accurate detection of SVs, many of which have been shown to be associated with human disease as well as complex traits in plants and animals. As a complementary tool to next-generation sequencing (NGS), NGM integrates with sequence assemblies to create contiguous hybrid scaffolds for reference-quality genome assemblies that reveal the highly informative native structure of the chromosome. NGM also provides the additional ability to verify, correct and improve a NGS-generated genome assembly.

Only Bionano provides long-range genomic information with the cost-efficiency and high throughput to keep up with advances in NGS.

NGM has been adopted by a growing number of leading institutions around the world, including: National Cancer Institute (NCI), National Institutes of Health (NIH), Wellcome Trust Sanger Institute, BGI, Garvan Institute, Salk Institute, Mount Sinai and Washington University. Investors in the Company include Domain Associates, Legend Capital, Novartis Venture Fund and Monashee Investment Management.

For more information, please visit http://www.BionanoGenomics.com.

Notes: Bionano Genomics is a trademark of Bionano Genomics, Inc. Any other names of actual companies, organizations, entities, products or services may be the trademarks of their respective owners.

See the rest here:
Nature Genetics Paper Demonstrates How Inclusion of Bionano Genomics' Next-Generation Mapping is Essential to ... - Yahoo Finance

Tennessee bird flu shares name, not genetics, of feared China strain … – Reuters

By Tom Polansek | CHICAGO

CHICAGO The strain of bird flu that infected a chicken farm in Tennessee in recent days shares the same name as a form of the virus that has killed humans in China, but is genetically distinct from it, U.S. authorities said on Tuesday.

The U.S. Department of Agriculture identified the strain in Tennessee as H7N9, following a full genome sequencing of samples from the farm. It said all eight gene segments of the virus had North American wild bird lineage.

On Sunday, the USDA confirmed the farm in Tennessee was infected with highly pathogenic bird flu, making it the first case in a commercial U.S. operation in more than a year.

In China, at least 112 people have died from H7N9 bird flu this winter, Xinhua news agency said on Friday.

However, that virus has Eurasian lineage, U.S. flu experts said.

"Even though the numbers and the letters are the same, if you look at the genetic fingerprint of that virus, it is different," said Dan Jernigan, director of the influenza division at the National Center for Immunization and Respiratory Diseases at U.S. Centers for Disease Control and Prevention.

Jernigan said the risk to humans from the virus found in Tennessee is low. Genome sequencing shows the H7N9 virus did not have genetic features present in the virus in China that make it easier for humans to become infected, he said.

The virus found in Tennessee likely mutated to become highly pathogenic from a less dangerous, low pathogenic form, he said.

Disease experts fear a deadly strain of bird flu could mutate into a form that could be passed easily between people and become a pandemic.

Multiple outbreaks of the virus have been reported in poultry farms and wild flocks across Europe, Africa and Asia in the past six months. Most involved strains that were low risks for human health, but the sheer number of different types, and their simultaneous presence in so many parts of the world, has increased the risk of viruses mixing and mutating - and possibly jumping to people, according to disease experts.

China's Center for Disease Control and Prevention has said the majority of people infected by H7N9 in China reported exposure to poultry, especially at live markets.

Identifying the viruses in Tennessee and China both as H7N9 is similar to having two cars from different states with the same license plate number, said Carol Cardona, avian flu expert at the University of Minnesota.

The strain in Tennessee "is NOT the same as the China H7N9 virus that has impacted poultry and infected humans in Asia," the USDA emphasized in a statement.

"While the subtype is the same as the China H7N9 lineage that emerged in 2013, this is a different virus and is genetically distinct from the China H7N9 lineage," the USDA added.

U.S. officials are working to determine how the Tennessee farm, which was a supplier to Tyson Foods Inc, became infected. All 73,500 birds there were killed by the disease or suffocated with foam to prevent its spread.

Tyson, the world's biggest chicken company, is "hopeful this is an isolated incident," spokesman Worth Sparkman said.

Authorities have not identified the name of the farm or the town in Lincoln County, Tennessee, where it is located.

(Editing by Matthew Lewis and Bernard Orr)

SARAJEVO Nejra Isaretovic, a 25-year old physiotherapist from Sarajevo, is busy these days studying German and taking driving lessons -- key skills required for her new job in Germany.

The U.S. Department of Veterans Affairs said on Wednesday that it intends to expand mental health care to former service members with other-than-honorable (OTH) administrative discharges.

(Reuters Health) - Improvement or worsening of chest pain symptoms and quality of life after a CT scan of the heart may depend on what the scan finds, a large study suggests.

Go here to read the rest:
Tennessee bird flu shares name, not genetics, of feared China strain ... - Reuters

Want To Play Inside A Human Cell? Genius Games To Launch A Kickstarter Campaign That Will Let You – Yahoo Finance

ST. LOUIS, March 9, 2017 /PRNewswire/ --There are many mysteries unfolding every second at the cellular level inside the human body, and the board game scientists at Genius Games want to help you unravel them in their latest hard-science based strategy game, Cytosis: A Cell Biology Game. It is the first game in the world to be designed totally around the actual structure and dynamics of the human cell, and promises a vividly visual, tactile, and interactive tour of this essential building block of life.

The creators of award-winning biology and chemistry games (as well as children's books) will take players inside a human cell in Cytosis: A Cell Biology Game, where they will compete to build enzymes, hormones and receptors and fend off attacking Viruses! In 2016,Cytosis: A Cell Biology Gamewas the highest rated game during the prestigious Stonemaier Game Design Day, a day dedicated to play-testing prototypes, game design and idea exchange within the gaming community.

Well-known inside the scientific, teaching and gaming communities, the company is thrilled to announce their upcoming Kickstarter campaign for Cytosis: A Cell Biology Game, the latest addition to its growing product portfolio of games that have been heralded by both the gaming and scientific communities. In the company's latest board game, science becomes fun and learning becomes addictive when taught by the team at Genius Games. The company has had six other successful crowdfunded projects come to market. The Kickstarter campaign for Cytosis: A Cell Biology Game aims to raise $14,500. Donors pledging $39 or more will receive a copy of the game. Find more details on Cytosis: A Cell Biology Game here, and to reserve a copy, click the "Support This Project" button.

"We are excited to return to Kickstarter to seek funding for our latest board game venture, Cytosis: A Cell Biology Game. People familiar with our other products will find the same level of quality and creativity that they've come to expect from us," noted John Coveyou, founder and director of Genius Games. "Traditionally games are only meant for entertainment and school is where you go to learn. At Genius Games we have always felt that you can make learning fun. That is our mission, to develop games that are not only a blast to play, but that also simultaneously demystify intimidating science concepts. And for a cool behind-the-scenes look into the design, and launch of the game on Kickstarter, check out my new YouTube documentary series, A Kickstarter Launch Story."

"Cytosis is a really well-designed hard science game. The worker placement works extremely well Great game!," raved Paul Salomon, an expert Board Game Geek reviewer.

In Cytosis: A Cell Biology Game, players compete to build enzymes, hormones and receptors to fend off attacking viruses inside a human cell. The player with the most Health Points at the end of the game wins!

Players utilize the available organelles within the cell to collect cellular resources such as mRNA from the Nucleus, Lipids from the Smooth E.R., ATP from the Mitochondria, or transport Carbohydrates into the cell via endocytosis through the Plasma Membrane.Players may also utilize the organelles to Translate mRNA into Proteins (either on the Free Ribosome in the Cytoplasm, or in the Rough E.R) or add glucose or lipid tags to their hormonesor hormone receptors in the Golgi Apparatus.Players score health points when they complete any of the Hormone, Receptors or Enzyme cards. For 2-5 players, ages 10 and up. The game will be available nationwide in August for $44.99 MSRP.

Read More

About Genius GamesSt. Louis, Missouri based Genius Games was founded by John Coveyou in 2014. Genius Games is a game design company that publishes high-quality tabletop games that are both entertaining and educational. For more information, please visit https://gotgeniusgames.com/.

About John CoveyouJohn Coveyou, creator and designer of Cytosis: A Cell Biology Game, nearly dropped out of school in his teen years and spent a stint living out of his car. However, after serving in the military, he pursued his love of science at Washington University, earning his Masters in Energy, Environmental and Chemical Engineering. He later quit his posh engineering job to launch Genius Games in 2014. He now teaches courses on Game Design and Crowdfunding at Webster University in St. Louis along with running Genius Games full time.

Cytosis is the sixth science-based game created by Coveyou. His previous Kickstarter campaigns were wildly successful! Coveyou also published My FirstScience Textbooks and Science Wide Open, science storybooks for kids, which are still the fourth and sixth most funded children's book campaign to date on Kickstarter.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/want-to-play-inside-a-human-cell-genius-games-to-launch-a-kickstarter-campaign-that-will-let-you-300420868.html

Continued here:
Want To Play Inside A Human Cell? Genius Games To Launch A Kickstarter Campaign That Will Let You - Yahoo Finance

Scott Foley’s ‘dead head’ freaks out his wife on Grey’s Anatomy – TV3.ie

9th Mar 17 | Entertainment News

Scott Foley's actress wife freaked out when she saw her first 'dead body' on Grey's Anatomy, because her husband was looking up at her.

Marika Dominczyk has started work on the medical drama that once featured her man as Henry Burton, and she didn't realise the show's prop team recycle Scott's dead head whenever they need a corpse.

"They not so kindly killed me off," he recalls, "but to do so, they made a full prosthesis of my head, and those things are expensive to make, so they don't make a bunch of them.

"Every time they have a dead body or a cadaver laying on a table, it's my head... The first time she had no idea; they didn't tell her... She was like, 'Oh God!'"

Marika, who plays lesbian Dr. Eliza Minnick on the current season of the show, has just returned to acting after taking time off to focus on being a mum to her three kids with Foley. She previously featured in TV drama North Shore and played Bernadette in The 40-Year-Old Virgin.

"She spent seven years raising our children and now that she had the opportunity to go back to work she was really chomping at the bit," Foley tells Access Hollywood Live. "This part came along and she's knocking it out the park... She looks great in a doctor's coat."

But he's not looking forward to sitting down with his wife's TV lover, Jessica Capshaw, and her husband now the old friends are kissing on TV.

"We've known socially Jessica Capshaw and her husband Christopher Gavigan for years, so it was a little strange for them," he explains. "I don't think we've had the chance to talk about it yet. That'll be an interesting conversation."

WENN Newsdesk 2017

Link:
Scott Foley's 'dead head' freaks out his wife on Grey's Anatomy - TV3.ie

McGill ranked world’s 3rd best university for study of Anatomy & Physiology – McGill Newsroom

McGill University is the worlds third-best university for the study of Anatomy & Physiology, behind only the Universities of Oxford and Cambridge, according to the 2017 QS World University Rankings by Subject.

The seventh edition of QS Quacquarelli Symondss analysis of subject-specific university performance, released today, lists the worlds best universities for the study of 46 different subjects. Anatomy & Physiology is one of four new subject categories introduced in this years listing.

We are extremely pleased to rank among the worlds top three universities in the study of anatomy and physiology, said David Eidelman, Vice-Principal of Health Affairs and Dean of Medicine at McGill. This is a direct outcome of the quality of our academics and staff in these departments, who I congratulate for their stellar and hard work on behalf of our students. I am also gratified to see McGills rankings rise this year in the medicine and pharmacology categories.

McGills ranking in the Medicine subject category rose to 22nd this year from 27th in 2016. In Pharmacology, McGill moved up to the 31st spot from 37th a year ago.

Another standout performance came in the Engineering Mineral and Mining category, with McGill rising to a tie for sixth place globally this year from 13th place last year. We are very proud to be ranked so highly along with our counterparts in other Canadian institutions, said Jim Nicell, McGills Dean of Engineering. The mining industry is an essential part of the economy of Canada, so we must always do our best to stay at the forefront in our teaching and research in support of this sector.

More broadly, McGill is listed this year in the top 50 in 7 of 10 subjects in Arts & Humanities, 3 of 6 subjects in Engineering & Technology, 7 of 9 in Life Sciences & Medicine, 6 of 7 in Natural Sciences, and 9 of 14 in Social Sciences & Management.

The full QS World University Rankings by Subject tables can be foundhere. The full methodology can be foundhere.

Read the original post:
McGill ranked world's 3rd best university for study of Anatomy & Physiology - McGill Newsroom

Behind the scenes of cardiac physiology at Salisbury District Hospital – Salisbury Journal

CARDIAC physiologists carry out a range of investigations for people with potential, or known, heart problems.

Their work includes performing electrocardiograms (ECGs), putting people on treadmills to evaluate their hearts response to exercise, performing cardiac ultrasound scans, checking and programming implanted pacemakers and implantable defibrillators, and monitoring the blood pressure and heart rhythm while stents are fitted in the cardiac catheter lab.

Claire Murray, a cardiac physiologist at Salisbury District Hospital, said: We are involved with any investigation relating to your heart. We see everybody from babies to the elderly if patients have a problem with their heart, we are involved in their care.

Cardiac physiology is one of more than 20 healthcare sciences. They involve the life sciences such as microbiology, histology and genetics, the physical sciences like medical engineering, medical physics and nuclear medicine and then the physiological sciences with people going into audiology and neurophysiology, Claire says.

Cardiac physiology is very patient-focused, which is what appealed to me.

Some of the other healthcare sciences are much more in the lab or using physics.

Cardiology is always changing theres a lot of investment into cardiac health care and theres always research going on and new developments.

We use a lot of technology and equipment and there is always something to learn which I really enjoy.

You get that feeling of really making a difference if someone comes in with a heart rate of 20 and has a pacemaker fitted, theyre instantly better. Thats so satisfying.

Procedures generally take between 10 minutes and half an hour with a cardiac physiologist writing up a report after analysing results. We are quite autonomous in our working, Claire says. For example, after doing an ultrasound, we would create a technical report on what we have found which goes back to the clinician whos asked us to do it and they will then prescribe medication or further procedures.

The most common route into cardiac physiology is a BSc in clinical physiology. Once complete, you are a healthcare science practitioner, becoming a scientist after completing the three-year Scientist Training Programme (STP).

People are educated to different levels within the scientific banner people have come in with degrees in medical engineering or microbiology, a lot of people have masters or PhDs, Claire says.

As healthcare scientists our careers have come across quite convoluted paths to get to where we are currently in the healthcare science programme.

Today, everyone will be doing science and maths as A-levels but after that point it can be very split. A lot of our scientist programmes are done as part of a national recruitment process to train people.

Previously, as a trainee cardiac physiologist, you would be employed by a hospital and do your training over four years which involved being hospital-based and going to university on block release but now you come out of university with qualifications and then look for a job.

Claires own route into the profession involved going straight from GCSEs into a two-year regional training programme.

I started in 1990, she said. The first eight months was spent in audiology, neurophysiology, respiratory physiology and cardiology. After that I chose which one and as I just loved cardiology, I spent the rest of the two years on that, doing a BTEC in medical physics and physiological measurements.

Claire has been at SDH for 15 years and is one of 12 cardiac physiologists. For any students considering a career in cardiac physiology, you have to be of scientific mind and enjoy the sciences, she says.

Its important to like working with people, you need to be prepared to talk to anybody, have excellent communication skills as we often have to explain complicated information to our patients or their carers, and have an interest in technology because everything we do is with medical equipment.

Its also about being able to keep calm in stressful situations and work as a team.

From a practical aspect, we dont tend to work shifts, although some of our role includes being on call from home, so it is very appealing from that point of view.

Read the original post:
Behind the scenes of cardiac physiology at Salisbury District Hospital - Salisbury Journal

Author Kevin Davis on neuroscience in the courtoom: It made what would have been a regular domestic violence … – WGN Radio

The Brain Defense: Murder in Manhattan and the Dawn of Neuroscience in America's Courtrooms (BN.com)

The Brain Defense: Murder in Manhattan and the Dawn of Neuroscience in America's Courtrooms (BN.com)

Author Kevin Davis has just had his book, The Brain Defense: Murder in Manhattan and the Dawn of Neuroscience in Americas Courtrooms. The book explores the case of Herbert Weinstein, who mysteriously admitted to murdering his wife, following an argument. Kevin explains changes in the justice system inspired by an orange-sized cyst in Weinsteins brain.

View post:
Author Kevin Davis on neuroscience in the courtoom: It made what would have been a regular domestic violence ... - WGN Radio

Cattle Genetics | BEEF Magazine

A chance encounter on a country drive led to the export of 2,400 heifer calves to Turkey.

The promise of genetic editing is that it enables the deletion or insertion of a couple of base pairs in the DNA...

What are your cattle operations genetic goals? There's plenty at stake if you don't know them, or even worse...

Sign Up for the BEEF Daily newsletter today!

Cow-calf producers who dont use science when selecting genetics may find their herd on the wrong end of a smoking gun.

The beef business is moving from a segmented industry to one thats more united, and information is at the core of that shift. Genomic data is helping that transition.

The world is watching what we do and how we do it. And that need for transparency will soon hit our use of genomic technology. We need to get ready.

A cowherds ability to maintain a high weaning rate with minimal supplementation of harvested feeds is a key contributor to a ranchs overall sustainability.

BEEFs 3rd annual Seedstock 100 listing, which ranks seedstock producers by number of bulls sold, offers you a glimpse at some...

Can you breed cattle to follow the road less traveled and graze hillsides? Research says its possible.

This exclusive gallery features photos and information on the 100+ operations that make up the annual Seedstock 100 listing.

Bull buying season is nigh, and since your bull battery contributes 75% of your genetics, taking a little time to prepare ahead of the sale is time well spent. Those tips and more await you in this weeks Trending Headlines.

With most genetics available to everyone, increasingly, the primary point of differentiation among seedstock suppliers is their understanding of customer needs. That takes a relaetionship.

As the art and science of genomics becomes more accurate, cow-calf producers benefit. While cow-calf producers wont directly participate in genomic evaluation now that single-step evaluation is a reality, theyll be able to buy bulls with more...

Read the original here:
Cattle Genetics | BEEF Magazine

This Very Rare Emoji Snake Is a Genetics Marvel – Inverse

It wasnt until a few weeks after the albino ball python hatched that Justin Kobylka noticed it was distinctly marked with three smiley faces. He saw one a yellow blob that looks like a smiling emoji and thought it was cool. Then, when reviewing a photograph of the snake, he noticed they comprised a trio a pattern that he, a professional snake breeder, had never heard of. He was in the presence of a rare masterwork of genetic engineering.

I knew theoretically that you could get smiley faces one smiley face is not that uncommon, said Kobylka, who hatched his first batch of snakes in an incubator underneath his dorm room bed in college, in an interview with Inverse. I would likely be able to breed more in the future that have just one, but I dont know if I could get three ever again no matter how long I try. Its really a lucky thing.

This snakes existence is a mixture of luck and years worth of careful science. While the snakes unique pattern is what makes it viral worthy, what is less obvious is how difficult it is for a highly patterned albino that is, white-skinned ball python to even exist.

There are two recessive mutations, fairly common in the natural world, manifested this snake: albinism and pybalism, the characteristic of having high-color, high-contrast patterns like the smiley face. The first albino ball python that ever hatched was bred from double heterozygous parent snakes that both contained mutant alleles at both genes encoding these two traits. Because the odds are one in 16 that a snake carrying both mutations could hatch and each female only has six eggs a year, it could take two to three years for this breeding to even occur, Kobylka says.

Breeding gets easier once the first albino pyball is born: Using it in a second pairing with another double heterozygous parent, the odds drop to one in four. Still, theres no guarantee that the albino pyballs characteristic splotch pattern will form the shape of a smiley, let alone three times in a row; it occurs in only one in ten snakes. This is where Kobylkas luck factors in.

The special smilies are fun, but were just happy to be able to make an albino ball python, says Kobylka. Two years ago, making an albino ball python was a holy grail.

When these special snakes hatched, they were worth a pretty penny for collectors; they are valued between $30,000 to $40,000. Today, Kobylka can use an albino python in the actual pairing as a double homozygous animal as the parent, which drops the odds to another albino ball python hatching to one in four. While this easier breeding system has increased the quantity available, and has dropped the price to about $4,500 each.

Is it possible for you to get an emoji snake exactly like this? Probably not science isnt on your side and Kobylka is keeping this one.

Photos via Giphy

Read the original:
This Very Rare Emoji Snake Is a Genetics Marvel - Inverse